Article Information
History
- February 8, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 8, 2021 - 03:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vitor Heidrich1,2,#,
- Julia S. Bruno1,#,
- Franciele H. Knebel1,#,
- Vinícius C. de Molla3,4,#,
- Wanessa Miranda-Silva1,
- Paula F. Asprino1,
- Luciana Tucunduva3,
- Vanderson Rocha3,5,6,
- Yana Novis3,
- Celso Arrais-Rodrigues3,4,
- Eduardo R. Fregnani3 and
- Anamaria A. Camargo3,*
- 1Centro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, SP, Brazil
- 2Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil
- 3Centro de Oncologia, Hospital Sírio-Libanês, São Paulo, SP, Brazil
- 4Universidade Federal de São Paulo, São Paulo, SP, Brazil
- 5Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo/ICESP, São Paulo, SP, Brazil
- 6Churchill Hospital, NHS-BT, Oxford, United Kingdom
- ↵*Corresponding author:
Anamaria Aranha Camargo, E-mail: anamaria.acamargo{at}hsl.org.br, Centro de Oncologia Molecular, Hospital Sírio-Libanês, Rua Prof. Daher Cutait, 69, 01308-060 São Paulo - SP - Brasil, Phone: +55 11 3394-4180
↵# These authors contributed equally to this work
Posted February 08, 2021.
Dental biofilm microbiota dysbiosis is associated with the risk of aGVHD after allogeneic HSCT
